Category Archives: Human Longevity

The factors responsible for the development of this market are increasing emphasis on stem cell research, increasing demand for cell-based assays in research and development, and increasing geriatric population across the globe. The globallongevity and anti-senescence therapymarket accounted for US$ 361.6 Million in 2019 and is estimated to be US$ 1397.1 Million by 2029 and is anticipated to register a CAGR of 14.5% Continue reading →

Watching frontline health care workers and other volunteers receive their first doses of the COVID-19 vaccine, there is reason to believe after months of uncertainty that this pandemic will indeed end. The challenge now, though, is to keep ourselves safe until enough of us have been inoculated and possess protective immunity. Continue reading →

The Global Longevity and Anti-senescence Therapy Market comprises market size, status, and growth rate for the forecast period 2021-2026. The report offers fundamental data to readers, strategists, senior administration, and advertisers associated with the market. This unique and updated report precisely presents each and every aspect of the Global Longevity and Anti-senescence Therapy industry and represents it in an easy to understandable format Continue reading →

Coronavirus-Covid 2019 has a significant impact on the global market economy, so it is important to find a correct strategy to deal with it. Our analysis team will track key datasets including Revised Vendor Landscape Mix, Revenue Impact analysis, New opportunities mapping, Disruptions and New opportunities in the Supply Chain etc. A new analytical data report titled Precision Medicine Software market has been published by Research N Reports. Continue reading →

NEW YORK, Dec. 18, 2020 /PRNewswire/ --Capt. Continue reading →

Data Bridge Market Research Added A New Report on Personalized Cell Therapeutic Market That Provides A Comprehensive Review of This Industry with Respect to The Driving Forces Influencing The Personalized Cell Therapeutic Market Size. Comprising the Current and Future Trends Defining the Dynamics of This Industry Vertical, This Report Also Incorporates The Regional Landscape Of Personalized Cell Therapeutic Market In Tandem With Its Competitive Terrain. Personalized Cell Therapeutic Market Insight: Personalized cell therapeutic market is expected to gain market growth in the forecast period of 2020 to 2027 Continue reading →

The lovely thing about the American Constitution is that it is based on the premise that all residents have the right to life, liberty and the pursuit of happiness. And that is it. It is left up to us on how to make that life and pursue that happiness in a way that affords others to do the same. Continue reading →

The lovely thing about the American Constitution is that it is based on the premise that all residents have the right to life, liberty and the pursuit of happiness. Continue reading →

Ready to blast off and join thousands of attendees around the world atTC Sessions: Space 2020 on December 16-17? The event, focused on space technology and dedicated to helping early-stage startups succeed in this exciting yet daunting industry, features panel discussions and interviews with the top leaders, visionaries and makers on the planet. Want to save $50? Continue reading →

Twenty years ago, President Bill Clinton announced completion of what was arguably one of the greatest advances of the modern era: the first draft sequence of the human genome. "Without a doubt, this is the most important, the most wondrous map ever produced by humankind," Clinton said on June 26, 2000 from the White House, predicting that genome science "will revolutionize the diagnosis, prevention and treatment of most, if not all, human diseases." In the future, he said, "doctors will increasingly be able to cure diseases like Alzheimer's, Parkinson's, diabetes, and cancer by attacking their genetic roots." And indeed, the sequencing of the human genome achieved simultaneously by the Human Genome Project (HGP), an international consortium begun in 1990 and led by Francis Collins, MD, then director of the National Human Genome Research Institute, and by J. Craig Venter, PhD, with his team at the privately held Celera Genomics has revolutionized the approach to human health. Continue reading →